The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and Cancer

Published:2010-07 Issue:1 Volume:116 Page:76-84
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Castle Philip E.,Fetterman Barbara,Thomas Cox J.,Shaber Ruth,Poitras Nancy,Lorey Thomas,Kinney Walter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference26 articles.

1. Adding a test for human papillomavirus DNA to cervical-cancer screening.;Wright;N Engl J Med,2003

2. American Cancer Society guideline for the early detection of cervical neoplasia and cancer.;Saslow;CA Cancer J Clin,2002

3. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.;Wright;Obstet Gynecol,2004

4. The 2001 Bethesda System: terminology for reporting results of cervical cytology.;Solomon;JAMA,2002

5. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.;Wright;JAMA,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of cervical precancers or cancers in women with ASC-H/HSIL cytology according to Aptima HPV (AHPV) assay-detected HPV genotypes and age;Journal of Cancer;2024

2. Significant outcomes associated with high-risk human papillomavirus negative Papanicolaou tests;Journal of the American Society of Cytopathology;2023-05

3. It's time to re-evaluate cervical Cancer screening after age 65;Gynecologic Oncology;2021-07

4. Aptima HPV messenger RNA testing and histopathologic follow‐up in women with HSIL cytology: A study emphasizing additional review of HPV‐negative cases;Cancer Cytopathology;2021-03-25

5. Risk-based cervical screening guidelines should utilize large diverse national database and specifically measure invasive cancer risk of screened patients;Gynecology and Obstetrics Clinical Medicine;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3